Internal Medicine, Gastroenterology · Wesley Chapel, FL
NPI
1235228776
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2050 Ashley Oaks Cir Ste 102
Wesley Chapel, FL, 33544
Phone (813) 994-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
1,862 services
Medicare patients, 2024
473
Average age 74
Drug cost, 2024
$1.8M
2,282 prescriptions
Company payments, 2025
$3,832
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saeed Ahmed was code 99214 (office e&m - established), 627 times for 333 patients. In total Saeed Ahmed billed 1,862 services in 55 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 627 | 333 | $94.96 | $60K |
| 88305 Surgical Pathology Examination | Office | 234 | 76 | $28.34 | $6,632 |
| 88313 Surgical Pathology Examination | Office | 128 | 40 | $9.47 | $1,212 |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 79 | $95.91 | $12K |
| 88312 Surgical Pathology Examination | Office | 111 | 36 | $20.68 | $2,295 |
| 99204 Office E&M - New | Office | 107 | 107 | $122.59 | $13K |
| 43239 Upper GI Endoscopy | Facility | 79 | 75 | $71.21 | $5,626 |
| 99223 Hospital E&M - Initial | Facility | 69 | 68 | $138.04 | $9,525 |
| 88342 Immunohistochemistry | Office | 60 | 40 | $27.01 | $1,621 |
| 45380 Lower GI Endoscopy - Other | Facility | 51 | 51 | $120.03 | $6,121 |
| 45385 Colonoscopy - Lesion Removal | Facility | 38 | 38 | $217.41 | $8,262 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 25 | 25 | $176.95 | $4,424 |
| 43249 Upper GI Endoscopy | Facility | 23 | 22 | $117.65 | $2,706 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 20 | $63.62 | $1,272 |
| 45378 Lower GI Endoscopy - Other | Facility | 14 | 13 | $138.15 | $1,934 |
By year: 2022 $227K for 2,462 services; 2023 $164K for 1,918 services; 2024 $157K for 1,862 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 234 | 76 | $28.34 | $6,632 |
| 88313 Surgical Pathology Examination | 128 | 40 | $9.47 | $1,212 |
| 88312 Surgical Pathology Examination | 111 | 36 | $20.68 | $2,295 |
| 88342 Immunohistochemistry | 60 | 40 | $27.01 | $1,621 |
Medicare prescription drug claims, 2024
In 2024, the drug Saeed Ahmed prescribed most often to Medicare patients was Pantoprazole Sodium, with 544 prescriptions and refills. In total Saeed Ahmed wrote 2,282 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 544 | 1,503 | 241 | $6,412 |
| Famotidine Generic | 422 | 1,136 | 177 | $4,994 |
| Linzess Linaclotide | 156 | 356 | 69 | $175K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 102 | 102 | 93 | $6,333 |
| Dicyclomine Hcl Generic | 101 | 174 | 42 | $3,021 |
| Colestipol Hcl Generic | 68 | 128 | 24 | $4,878 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 66 | 66 | 62 | $9,404 |
| Xifaxan Rifaximin | 64 | 76 | 16 | $199K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 49 | 49 | 49 | $858 |
| Omeprazole Generic | 45 | 111 | 18 | $347 |
| Mesalamine Generic | 44 | 91 | 14 | $14K |
| Mesalamine Er Mesalamine | 38 | 97 | 14 | $8,346 |
| Humira(Cf) Pen Adalimumab | 36 | 36 | Under 11 | $242K |
| Trulance Plecanatide | 28 | 48 | Under 11 | $25K |
| Budesonide Dr Budesonide | 27 | 47 | Under 11 | $3,131 |
Brand drugs: - claims; generic drugs: 1,634 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saeed Ahmed $3,832 ($3,832 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $861.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 52 | $861 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 17 | $274 |
| Pfizer Inc. PFE | 12 | $218 |
| Janssen Biotech, Inc. JNJ | 13 | $214 |
| Evoke Pharma, Inc. EVOK | 9 | $206 |
| Novo Nordisk Inc NVO | 6 | $188 |
| Ardelyx, Inc. ARDX | 15 | $184 |
| Madrigal Pharmaceuticals MDGL | 9 | $155 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.